<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-219-11-5-11</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2593</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Гастрит и язвенная болезнь связаны с более низким уровнем липидов в плазме: возможно участие гистамина</article-title><trans-title-group xml:lang="en"><trans-title>Gastritis and peptic ulcers are associated with the lower levels of plasma lipids: possible involvement of histamine</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мохсен</surname><given-names>Лай</given-names></name><name name-style="western" xml:lang="en"><surname>Mohsen</surname><given-names>Laiegh</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хафез</surname><given-names>Фахери</given-names></name><name name-style="western" xml:lang="en"><surname>Hafez</surname><given-names>Fakheri</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мехди</surname><given-names>Расули</given-names></name><name name-style="western" xml:lang="en"><surname>Mehdi</surname><given-names>Rasouli</given-names></name></name-alternatives><email xlink:type="simple">mehdi.rasouli@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Мазандаранский университет медицинских наук<country>Россия</country></aff><aff xml:lang="en">Mazandaran University of Medical Sciences<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>26</day><month>03</month><year>2024</year></pub-date><volume>0</volume><issue>11</issue><fpage>5</fpage><lpage>11</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мохсен Л., Хафез Ф., Мехди Р., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Мохсен Л., Хафез Ф., Мехди Р.</copyright-holder><copyright-holder xml:lang="en">Mohsen L., Hafez F., Mehdi R.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2593">https://www.nogr.org/jour/article/view/2593</self-uri><abstract><p>Введение: Гистаминовые рецепторы участвуют в регуляции липидного обмена, поэтому возникает гипотеза о том, что патологические состояния с аномальными уровнями гистамина связаны с измененными липидами плазмы. Цель: изучить профиль липидов плазмы крови у больных гастритом и язвенной болезнью (ГЯ). Методы: В исследовании случай-контроль 70 пациентов с диспепсией были отобраны в соответствии с клиническими критериями и с помощью гастродуоденоскопии и сравнены с нормальными субъектами того же пола и возраста. Результаты. Между двумя группами не было выявлено существенных различий по возрасту, полу и распространенности гипертонии и диабета. Но аллергия, семейный анамнез аллергии и диспепсии, а также инфекция H. pylori были более распространены в группе больных по сравнению с контрольной группой. Уровни показателей воспаления и гидратации организма были одинаковыми в двух группах. У пациентов с диспепсией по сравнению с группой контроля наблюдались более низкие концентрации сывороточных триглицеридов (139,2±44,3 против 153,4±91,3), р≤0,553, общего холестерина (174,6±32,4 против 192,8±52,0, р≤0,073, ЛПНП (93,4±20,2) против 105,4±32,2, р≤0,015) и Non-HDLc (130,2±38,1 против 159,2±42,2, p≤0,008). Уровень ЛПВП достоверно не изменился (43,4±7,8 против 43,5±12,7, p≤0,930). Диспептическое состояние имело отрицательную значимую корреляцию с общим холестерином, ЛПНП и не-ЛПВП, но не с ЛПВП. Ни маркеры воспаления, ни показатели гидратации организма не имели значимой корреляции с ГПУ. Выводы: у пациентов с ГПА по сравнению с нормальной группой наблюдались более низкие уровни сывороточных липидов. Гиполипемические эффекты могут быть связаны с повышенным уровнем гистамина у пациентов с ГПА.</p></abstract><trans-abstract xml:lang="en"><p>Background: Histamine receptors are involved to regulate lipid metabolism, so the hypothesis will arise that pathological states with abnormal histamine levels are associated with altered plasma lipids. Objectives: To study the profile of plasma lipids in patients with gastritis and peptic ulcer (GPU). Methods: In a case-control study, 70 dyspeptic patients were selected according to clinical criteria and using gastroduodenoscopy and compared with sex and age matched normal subjects. Results: There were no significant differences in age, sex, and the prevalence of hypertension and diabetes between two groups. But allergy, the familial history of allergy and dyspeptic and H. pylori infection were more prevalent in case group compared with controls. The levels of the indices of inflammation and body hydration were the same in two groups. Patients with dyspeptic compared with the controls had the lower concentrations of serum triglyceride (139.2±44.3 vs. 153.4±91.3), p≤0.553), total cholesterol (174.6±32.4 vs. 192.8±52.0, p≤0.073, LDLc (93.4±20.2 vs. 105.4±32.2, p≤0.015) and NonHDLc (130.2±38.1 vs. 159.2±42.2, p≤0.008). The level of HDL had not a significant change (43.4±7.8 vs. 43.5±12.7, p≤0.930). Dyspeptic state had negative significant correlation with total cholesterol, LDLc and NonHDLc but not HDLc. Neither the markers of inflammation nor the indices of body hydration had significant correlation with GPU. Conclusions: The GPU patients relative to normal group had the lower levels of serum lipids. The hypolipemic effects may be attributed to increased level of histamine in GPU patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>холестерин</kwd><kwd>Гастрит</kwd><kwd>Липиды</kwd><kwd>Пептическая язва</kwd><kwd>Триглицериды</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Cholesterol</kwd><kwd>Gastritis</kwd><kwd>Lipids</kwd><kwd>Peptic ulcer</kwd><kwd>Triglycerides</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sherwood RA, Walsham NE, Bornason I. Gastric, pancreatic and intestinal function. In Rifai N, Horvath AR, Wittner CT eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th Edition, 2018, elsevier, pp. 1398-1421.</mixed-citation><mixed-citation xml:lang="en">Sherwood RA, Walsham NE, Bornason I. Gastric, pancreatic and intestinal function. In Rifai N, Horvath AR, Wittner CT eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th Edition, 2018, elsevier, pp. 1398-1421.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fujii T, Nakabayashi T, Hashimoto S, Kuwano H. Correlation between serum triglycerides and gastro-duodenal ulcer associated with low-dose aspirin. Hepatogastroenterology. 2009 Jul-Aug;56(93):1241-4. PMID: 19760979.</mixed-citation><mixed-citation xml:lang="en">Fujii T, Nakabayashi T, Hashimoto S, Kuwano H. Correlation between serum triglycerides and gastro-duodenal ulcer associated with low-dose aspirin. Hepatogastroenterology. 2009 Jul-Aug;56(93):1241-4. PMID: 19760979.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rasouli M, ed. Textbook of Medical Biochemistry. 4th Edition, Mazandaran, Roojin Mehr, 2015: 642-647.</mixed-citation><mixed-citation xml:lang="en">Rasouli M, ed. Textbook of Medical Biochemistry. 4th Edition, Mazandaran, Roojin Mehr, 2015: 642-647.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ong T.Z., Hawkey C.J., Ho K.Y. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study. J Clin Gastroenterol. 2006 Oct;40(9):795-800. doi: 10.1097/01.mcg.0000225610.41105.7f.</mixed-citation><mixed-citation xml:lang="en">Ong T.Z., Hawkey C.J., Ho K.Y. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study. J Clin Gastroenterol. 2006 Oct;40(9):795-800. doi: 10.1097/01.mcg.0000225610.41105.7f.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Peek R.M. Jr, Blaser M.J. Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am J Med. 1997 Feb;102(2):200-7. doi: 10.1016/s0002-9343(96)00273-2.</mixed-citation><mixed-citation xml:lang="en">Peek R.M. Jr, Blaser M.J. Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am J Med. 1997 Feb;102(2):200-7. doi: 10.1016/s0002-9343(96)00273-2.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Karpouza A., Samouilidou E., Karagiannis S. et al. Patients with duodenal ulcer have lower levels of serum cholesterol compared to other dyspeptic patients independently of Helicobacter pylori status. Scand J Gastroenterol. 2008 Aug;43(8):922-8. doi: 10.1080/00365520802008132.</mixed-citation><mixed-citation xml:lang="en">Karpouza A., Samouilidou E., Karagiannis S. et al. Patients with duodenal ulcer have lower levels of serum cholesterol compared to other dyspeptic patients independently of Helicobacter pylori status. Scand J Gastroenterol. 2008 Aug;43(8):922-8. doi: 10.1080/00365520802008132.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H.L., Jeon H.H., Park I.Y., Choi J.M., Kang J.S., Min K.W. Helicobacter pylori infection is associated with elevated low density lipoprotein cholesterol levels in elderly Koreans. J Korean Med Sci. 2011 May;26(5):654-8. doi: 10.3346/jkms.2011.26.5.654.</mixed-citation><mixed-citation xml:lang="en">Kim H.L., Jeon H.H., Park I.Y., Choi J.M., Kang J.S., Min K.W. Helicobacter pylori infection is associated with elevated low density lipoprotein cholesterol levels in elderly Koreans. J Korean Med Sci. 2011 May;26(5):654-8. doi: 10.3346/jkms.2011.26.5.654.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sung K.C., Rhee E.J., Ryu S.H., Beck S.H. Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults.Int J Cardiol. 2005 Jul 20;102(3):411-7. doi: 10.1016/j.ijcard.2004.05.040.</mixed-citation><mixed-citation xml:lang="en">Sung K.C., Rhee E.J., Ryu S.H., Beck S.H. Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults.Int J Cardiol. 2005 Jul 20;102(3):411-7. doi: 10.1016/j.ijcard.2004.05.040.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rasouli M., Kiasari A.M.Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease. Clin Biochem. 2006 Oct;39(10):971-7. doi: 10.1016/j.clinbiochem.2006.07.003.</mixed-citation><mixed-citation xml:lang="en">Rasouli M., Kiasari A.M.Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease. Clin Biochem. 2006 Oct;39(10):971-7. doi: 10.1016/j.clinbiochem.2006.07.003.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jia E.Z., Zhao F.J., Hao B. et al. Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis. 2009 Dec 23;8:59. doi: 10.1186/1476-511X-8-59.</mixed-citation><mixed-citation xml:lang="en">Jia E.Z., Zhao F.J., Hao B. et al. Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis. 2009 Dec 23;8:59. doi: 10.1186/1476-511X-8-59.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pieniazek P., Karczewska E., Duda A., Tracz W., Pasowicz M., Konturek S.J. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol. 1999 Dec;50(5):743-51. PMID: 10695556.</mixed-citation><mixed-citation xml:lang="en">Pieniazek P., Karczewska E., Duda A., Tracz W., Pasowicz M., Konturek S.J. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol. 1999 Dec;50(5):743-51. PMID: 10695556.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Buzás G.M. Metabolic consequences of Helicobacter pylori infection and eradication. World J Gastroenterol. 2014 May 14;20(18):5226-34. doi: 10.3748/wjg.v20.i18.5226.</mixed-citation><mixed-citation xml:lang="en">Buzás G.M. Metabolic consequences of Helicobacter pylori infection and eradication. World J Gastroenterol. 2014 May 14;20(18):5226-34. doi: 10.3748/wjg.v20.i18.5226.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kamada T., Hata J., Kusunoki H., Ito M., Tanaka S., Kawamura Y., Chayama K., Haruma K. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis. 2005 Jan;37(1):39-43. doi: 10.1016/j.dld.2004.07.017.</mixed-citation><mixed-citation xml:lang="en">Kamada T., Hata J., Kusunoki H., Ito M., Tanaka S., Kawamura Y., Chayama K., Haruma K. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis. 2005 Jan;37(1):39-43. doi: 10.1016/j.dld.2004.07.017.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Nikfar A., Rasouli M. Hypolipemic effects of histamine is due to inhibition of VLDL secretion from the liver: involvement of both H1 and H2-receptors. Arch Physiol Biochem. 2020;24:1-5. doi: 10.1080/13813455.2020.1782436.</mixed-citation><mixed-citation xml:lang="en">Nikfar A., Rasouli M. Hypolipemic effects of histamine is due to inhibition of VLDL secretion from the liver: involvement of both H1 and H2-receptors. Arch Physiol Biochem. 2020;24:1-5. doi: 10.1080/13813455.2020.1782436.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammadi-Pilehdarboni H, Rasouli M. Histamine H1- and H2-receptors participate to provide metabolic energy differently. Fundam Clin Pharmacol. 2022 Dec;36(6):1031-1037. doi: 10.1111/fcp.12814.</mixed-citation><mixed-citation xml:lang="en">Mohammadi-Pilehdarboni H, Rasouli M. Histamine H1- and H2-receptors participate to provide metabolic energy differently. Fundam Clin Pharmacol. 2022 Dec;36(6):1031-1037. doi: 10.1111/fcp.12814.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rasouli M., Trischuk T.C., Lehner R. Calmodulin antagonist W-7 inhibits de novo synthesis of cholesterol and suppresses secretion of de novo synthesized and preformed lipids from cultured hepatocytes. Biochim Biophys Acta. 2004 Jun 1;1682(1-3):92-101.doi: 10.1016/j.bbalip.2004.02.002.</mixed-citation><mixed-citation xml:lang="en">Rasouli M., Trischuk T.C., Lehner R. Calmodulin antagonist W-7 inhibits de novo synthesis of cholesterol and suppresses secretion of de novo synthesized and preformed lipids from cultured hepatocytes. Biochim Biophys Acta. 2004 Jun 1;1682(1-3):92-101.doi: 10.1016/j.bbalip.2004.02.002.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Rasouli M., Mokhtari H. Calculation of LDL-Cholesterol vs. Direct Homogenous Assay. J Clin Lab Anal. 2017 May;31(3):e22057. doi: 10.1002/jcla.22057.</mixed-citation><mixed-citation xml:lang="en">Rasouli M., Mokhtari H. Calculation of LDL-Cholesterol vs. Direct Homogenous Assay. J Clin Lab Anal. 2017 May;31(3):e22057. doi: 10.1002/jcla.22057.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rasouli M., Kiasari A.M., Arab S. Indicators of dehydration and haemoconcentration are associated with the prevalence and severity of coronary artery disease. Clin Exp Pharmacol Physiol. 2008 Aug;35(8):889-94. doi: 10.1111/j.1440-1681.2008.04932.x.</mixed-citation><mixed-citation xml:lang="en">Rasouli M., Kiasari A.M., Arab S. Indicators of dehydration and haemoconcentration are associated with the prevalence and severity of coronary artery disease. Clin Exp Pharmacol Physiol. 2008 Aug;35(8):889-94. doi: 10.1111/j.1440-1681.2008.04932.x.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Rasouli M., Nesarhosseini V., Kiasari A.M. et al. The multiplicative interactions of leukocyte counts with some other risk factors enhance the prognostic value for coronary artery disease. Cardiol J. 2011;18(3):246-53. PMID: 21660913.</mixed-citation><mixed-citation xml:lang="en">Rasouli M., Nesarhosseini V., Kiasari A.M. et al. The multiplicative interactions of leukocyte counts with some other risk factors enhance the prognostic value for coronary artery disease. Cardiol J. 2011;18(3):246-53. PMID: 21660913.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998 May 13;279(18):1477-82. doi: 10.1001/jama.279.18.1477.</mixed-citation><mixed-citation xml:lang="en">Danesh J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998 May 13;279(18):1477-82. doi: 10.1001/jama.279.18.1477.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kamada T., Hata J., Kusunoki H. et al. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis. 2005 Jan;37(1):39-43. doi: 10.1016/j.dld.2004.07.017.</mixed-citation><mixed-citation xml:lang="en">Kamada T., Hata J., Kusunoki H. et al. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis. 2005 Jan;37(1):39-43. doi: 10.1016/j.dld.2004.07.017.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Rozenberg I., Sluka S.H., Rohrer L. et al. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins. Arterioscler Thromb Vasc Biol. 2010 May;30(5):923-30. doi: 10.1161/ATVBAHA.109.201079.</mixed-citation><mixed-citation xml:lang="en">Rozenberg I., Sluka S.H., Rohrer L. et al. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins. Arterioscler Thromb Vasc Biol. 2010 May;30(5):923-30. doi: 10.1161/ATVBAHA.109.201079.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Yamada S., Wang K.Y., Tanimoto A., Sasaguri Y. Novel function of histamine signaling in hyperlipidemia-induced atherosclerosis: Histamine H1 receptors protect and H2 receptors accelerate atherosclerosis. Pathol Int. 2015 Feb;65(2):67-80. doi: 10.1111/pin.12246.</mixed-citation><mixed-citation xml:lang="en">Yamada S., Wang K.Y., Tanimoto A., Sasaguri Y. Novel function of histamine signaling in hyperlipidemia-induced atherosclerosis: Histamine H1 receptors protect and H2 receptors accelerate atherosclerosis. Pathol Int. 2015 Feb;65(2):67-80. doi: 10.1111/pin.12246.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Knoflach M., Kiechl S., Mayr A., Willeit J., Poewe W., Wick G. Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies. Arch Intern Med. 2005 Nov 28;165(21):2521-6. doi: 10.1001/archinte.165.21.2521.</mixed-citation><mixed-citation xml:lang="en">Knoflach M., Kiechl S., Mayr A., Willeit J., Poewe W., Wick G. Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies. Arch Intern Med. 2005 Nov 28;165(21):2521-6. doi: 10.1001/archinte.165.21.2521.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Rasouli M., Kiasari A.M.Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease. Clin Chem Lab Med. 2008;46(5):667-73. doi: 10.1515/CCLM.2008.137.</mixed-citation><mixed-citation xml:lang="en">Rasouli M., Kiasari A.M.Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease. Clin Chem Lab Med. 2008;46(5):667-73. doi: 10.1515/CCLM.2008.137.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bagheri B., Meshkini F., Dinarvand K., Alikhani Z., Haysom M., Rasouli M. Life Psychosocial Stresses and Coronary Artery Disease. Int J Prev Med. 2016 Sep 14;7:106. doi: 10.4103/2008-7802.190598.</mixed-citation><mixed-citation xml:lang="en">Bagheri B., Meshkini F., Dinarvand K., Alikhani Z., Haysom M., Rasouli M. Life Psychosocial Stresses and Coronary Artery Disease. Int J Prev Med. 2016 Sep 14;7:106. doi: 10.4103/2008-7802.190598.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
